Thromboaspiration and IIb/IIIa therapy in STEMI: abciximab redux?
Heart South Cardiovascular Group, Alabaster, Alabama; University of Alabama at Birmingham, Birmingham, Alabama.
William B
WB
Hillegass
Brigitta C
BC
Brott
D000077284:Abciximab; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003328:Coronary Thrombosis / Q000628:therapy*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use*; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention; D017131:Thrombectomy
D000911:Antibodies, Monoclonal; D005343:Fibrinolytic Agents; D007140:Immunoglobulin Fab Fragments; D000077284:Abciximab